Items where authors include "Hiley, C."

Article

Gimeno-Valiente, F., Castignani, C., Larose Cadieux, E. orcid.org/0000-0002-9320-8040 et al. (265 more authors) (2025) DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolution. Nature Genetics, 57 (9). pp. 2226-2237. ISSN 1061-4036

Fornacon-Wood, I., Banfill, K., Ahmad, S. et al. (22 more authors) (2023) Impact of the COVID-19 pandemic on outcomes for patients with lung cancer receiving curative-intent radiotherapy in the UK. Clinical Oncology, 35 (10). e593-e600. ISSN 0936-6555

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Salem, A., Franks, K., Greystoke, A. et al. (6 more authors) (2022) Unaccounted confounders limit the ability to draw conclusions from big data analysis comparing radiotherapy fractionation regimens in NSCLC. Journal of Thoracic Oncology, 17 (6). e55-e56. ISSN 1556-0864

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Banfill, K., Croxford, W., Fornacon-Wood, I. et al. (22 more authors) (2022) Changes in the management of patients having radical radiotherapy for lung cancer during the first wave of the COVID-19 pandemic in the UK. Clinical Oncology, 34 (1). pp. 19-27. ISSN 0936-6555

Punjabi, A., Barrett, E., Cheng, A. et al. (21 more authors) (2021) Neutrophil–lymphocyte ratio and absolute lymphocyte count as prognostic markers in patients treated with curative-intent radiotherapy for non-small cell lung cancer. Clinical Oncology, 33 (8). e331-e338. ISSN 0936-6555

Evison, M., Barrett, E., Cheng, A. et al. (20 more authors) (2021) Predicting the risk of disease recurrence and death following curative-intent radiotherapy for non-small cell lung cancer: The development and validation of two scoring systems from a large multicentre UK cohort. Clinical Oncology, 33 (3). pp. 145-154. ISSN 0936-6555

Faivre-Finn, C., Fenwick, J.D., Franks, K.N. et al. (11 more authors) (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32 (8). pp. 481-489. ISSN 0936-6555

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

McGranahan, N., Rosenthal, R., Hiley, C.T. et al. (93 more authors) (2017) Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell, 171 (6). 1259-1271.e11. ISSN 0092-8674

Conference or Workshop Item

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Proceedings Paper

Horne, A., Walls, G., Brown, S. et al. (17 more authors) (2025) An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC. In: Journal of Thoracic Oncology. European Lung Cancer Congress 2025, 26-29 Mar 2025, Paris, France. Elsevier BV , S150.

Corkhill, A., Woolf, D., Hatton, M. orcid.org/0000-0003-2778-7926 et al. (15 more authors) (2025) 252 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108361.

Hill, K., Woolf, D., Downs, N. et al. (16 more authors) (2025) 253 Prospective, randomised, multicentre trial of first line systemic treatment and radiotherapy in stage IV non-small cell lung cancer: PRINCE a candidate-specific trial within the TOURIST Platform. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108362.

Downs, N., Sutton, C., Corkhill, A. et al. (16 more authors) (2025) 254 Quality of life after radiotherapy treatment for patients with stage IV non-small cell Lung cancer: QUARTZ LUNG a candidate-specific trial within the TOURIST platform. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 2025-03-03 2025-03-05, Belfast, Northern Ireland. Elsevier BV , p. 108363.

Walls, G., Horne, A., Franks, K. et al. (23 more authors) (2025) 255 An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRis) in combination with conventional radiotherapy in NSCLC. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108364.

Horne, A., Brown, S., Gilbert, A. et al. (16 more authors) (2024) Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm. In: Radiotherapy and Oncology. ESTRO 2024, 03-07 May 2024, Glasgow, UK. , S1652-S1655.

Woolf, D., Downs, N., Sutton, C. et al. (15 more authors) (2024) 209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST. In: Lung Cancer. 22nd Annual British Thoracic Oncology Group Conference 2024, 17-19 Apr 2024, Belfast, Northern Ireland. Elsevier BV .

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.